Skip to main content
MedicHelpLine
Join Free
Verified Professional Network190+ CountriesHIPAA-Aware Platform
Back to Drug Index
General MedicationsINTRAMUSCULARStandard

TRIPTODUR KIT

TRIPTORELIN PAMOATE

Standard Dose
EQ 22.5MG BASE/VIAL
Max Dose
Refer to approved labeling
Primary Use
Review priority: STANDARD Marketing status: Prescription
Summary

Approval overview TRIPTODUR KIT is listed in Drugs@FDA under application 208956 (NDA).

Review priority: STANDARD Marketing status: Prescription Active ingredient TRIPTORELIN PAMOATE Form and strength FOR SUSPENSION, EXTENDED RELEASE;INTRAMUSCULAR - EQ 22.5MG BASE/VIAL Sponsor AZURITY Submission history Latest submission status date: 2025-09-23 00:00:00.

Structured Monograph

Clinical summary

Approval overview TRIPTODUR KIT is listed in Drugs@FDA under application 208956 (NDA). Review priority: STANDARD Marketing status: Prescription Active ingredient TRIPTORELIN PAMOATE Form and strength FOR SUSPENSION, EXTENDED RELEASE;INTRAMUSCULAR - EQ 22.5MG BASE/VIAL Sponsor AZURITY Submission history Latest submission status date: 2025-09-23 00:00:00. Submission type: SUPPL.

Monitoring

  • • Marketing status: Prescription
  • • Review priority: STANDARD

Interaction Notes

  • No interaction notes stored yet.
TRIPTODUR KIT (TRIPTORELIN PAMOATE) | Drug Monograph | MedicHelpline